[Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010417:Pentaerythritol Tetranitrate
Sperimentazione clinica dell'associazione di un farmaco betabloccante con un nitroderivato nella prevenzione degli accessi anginosi e nel trattamento di base delle insufficienze coronariche.